1) Antithrombin deficiency
抗凝血酶缺陷
2) Antithrombin deficiency
抗凝血酶缺陷症
3) anticoagulant
抗凝
1.
Study of changes of procoagulant,anticoagulant and fibrinolysis in patients withdeep vein thrombosis pretherapy between posttherapy;
下肢深静脉血栓形成患者溶栓前后凝血、抗凝和纤溶活性改变的研究
2.
Anticoagulant treatment on chronic non-valvalar atrial fibrillation in the elderly patients;
老年慢性非瓣膜房颤患者的抗凝治疗
3.
The effect of anticoagulant and thrombolytic therapy on arterial blood gas with acute pulmonary thromboembolism;
抗凝与溶栓治疗对急性肺血栓栓塞症患者血气的影响
4) anticoagulation
抗凝
1.
Anticoagulation of Warfarin Therapy in Patients After Mechanical Valve Implantation;
心脏机械瓣膜置换术后华法林抗凝观察
2.
Observation of Coagulation-anticoagulation and Fibrinolytic System Function in Abnormal Humour Syndrome Patients with Coronary Heart Disease;
异常体液型冠心病患者凝血、抗凝和纤溶系统功能的变化
3.
Study on the Association between the Maintenance Dose of Warfarin Anticoagulation Therapy and the Genetic Mutation of Cytochrome P450 (CYP2C9);
华法林抗凝治疗维持剂量与CYP2C9基因突变的关系
5) Anti-coagulation
抗凝
1.
Objective To investigate the change of the blood coagulation, fibrinolysis and anti-coagulation system indexes in patients with chronic pulmonary heart disease during acute stage and recovery stage.
目的研究慢性肺心病患者急性期和恢复期凝血、纤溶和抗凝指标的变化。
2.
Forty-two cases received surgery in addition to thrombolytic therapy,anti-coagulation and vasodilatation,and 5 cases were treated with drugs only.
4 2例行外科手术加抗凝、溶栓、扩血管治疗。
6) anticoagulation
抗凝血
1.
Preparation and anticoagulation evaluation of emodin/poly(lactic acid) composite films;
大黄素/聚乳酸物复合薄膜的制备及抗凝血研究
2.
Relationship between site of sulfate groups in cellulose sulfate and their anticoagulation activity;
硫酸酯基的位置与纤维素硫酸酯抗凝血活性关系
3.
Recent studies on the anticoagulation and antithrombosis pharmacology of polysaccharides in China;
国内抗凝血、抗血栓多糖的药理研究进展
参考词条
补充资料：抗凝血酶Ⅲ
抗凝血酶Ⅲ
血浆中一种抗丝氨酸蛋白酶。是人体内一类较重要的生理性抗凝物质。凝血因子Ⅱa、Ⅶ、Ⅸa、Ⅹa的活化中心均含有丝氨酸残基，都属于丝氨酸蛋白酶，ATⅢ分子上的精氨酸残基，可以与这些酶活性中心的丝氨酸残基结合，这样就"封闭"了这些酶的活性中心而使之失活。在血液中，每一分子ATⅢ，可以与一分子的凝血酶结合形成复合物，从而使凝血酶失活。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。